Pollmanns, M.R.; Pajaziti, Q.; Hohlstein, P.; Adams, J.K.; Abu Jhaisha, S.; Kabak, E.; Hamesch, K.; Nusser, S.H.A.; Weiskirchen, R.; Wirtz, T.H.;
et al. Serum Adiponectin Is Elevated in Critically Ill Patients with Liver Disease and Associated with Decreased Overall Survival. Biomedicines 2024, 12, 2173.
https://doi.org/10.3390/biomedicines12102173
AMA Style
Pollmanns MR, Pajaziti Q, Hohlstein P, Adams JK, Abu Jhaisha S, Kabak E, Hamesch K, Nusser SHA, Weiskirchen R, Wirtz TH,
et al. Serum Adiponectin Is Elevated in Critically Ill Patients with Liver Disease and Associated with Decreased Overall Survival. Biomedicines. 2024; 12(10):2173.
https://doi.org/10.3390/biomedicines12102173
Chicago/Turabian Style
Pollmanns, Maike R., Qendrim Pajaziti, Philipp Hohlstein, Jule K. Adams, Samira Abu Jhaisha, Elena Kabak, Karim Hamesch, Sophie H. A. Nusser, Ralf Weiskirchen, Theresa H. Wirtz,
and et al. 2024. "Serum Adiponectin Is Elevated in Critically Ill Patients with Liver Disease and Associated with Decreased Overall Survival" Biomedicines 12, no. 10: 2173.
https://doi.org/10.3390/biomedicines12102173
APA Style
Pollmanns, M. R., Pajaziti, Q., Hohlstein, P., Adams, J. K., Abu Jhaisha, S., Kabak, E., Hamesch, K., Nusser, S. H. A., Weiskirchen, R., Wirtz, T. H., & Koch, A.
(2024). Serum Adiponectin Is Elevated in Critically Ill Patients with Liver Disease and Associated with Decreased Overall Survival. Biomedicines, 12(10), 2173.
https://doi.org/10.3390/biomedicines12102173